News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC disappointed drug promoted

22 December 2004

PHARMAC disappointed drug promoted despite potential side-effects

PHARMAC is calling for drug companies to act more swiftly when concerns are raised over potential side effects and to be responsible in the promotion of their drugs.

The call follows reports that show arthritis drug Celebrex, a Cox-2 Inhibitor, more than doubles the risk of heart attacks and strokes. The latest findings follow the international withdrawal two months ago of another Cox-2 Inhibitor Vioxx due to similar side effects.

PHARMAC Chief Executive Wayne McNee says it was disappointing that Pfizer continued to aggressively promote Celebrex to doctors despite the withdrawal of Vioxx and similar concerns being raised about its own drug.

“A United States study raised concerns about Celebrex, and as a result the Food and Drug Administration asked Pfizer to voluntarily withdraw its advertising. However, it is concerning that despite this request, Pfizer has said that it will continue to promote the product to doctors.

“It is difficult to comprehend how a company can justify continuing to promote the safety of these drugs, and to claim there is no increased risk of cardiovascular events.”

Wayne McNee says the safety concerns around these drugs have been known for at least four years. PHARMAC decided in January not to fund Cox-2 Inhibitors based on the evidence of potential risk to patients.

“Drug companies must take these concerns very seriously, and it is irresponsible for them to continue to promote the benefits of drugs and ignoring the potential risks.”

He says when making the funding decision PHARMAC concluded that there was no evidence the COX-2 Inhibitors worked better than the older medicines.

“This shows clearly that new is not always better. Patient safety is always an important part of our decision making and in this case there were clear question marks over the side effects of these drugs.”


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Howard Davis: Troy Kingi Rules The San Fran

The award-winning Northland musician performed songs from his new record The Ghost of Freddie Cesar, the fourth installment in his 10/10/10 series - ten albums in ten years in ten genres. More>>

Howard Davis: The Phoenix Foundation Rises From The Ashes (& Chris O'Connor Talks)

Simultaneously dreamy and structured, understated and subtle, spacious and hypnotic, The Phoenix Foundation's new album Lifeline includes gorgeous vocal harmonies, lilting lyrics with no lack of wry, self-deprecating humour, and gently weeping guitar parts. More>>

Howard Davis: Estère At San Fran

Appearing at Wellington's San Fran to promote her new single, Calculated Risk, the local musician sutured together a highly impressive set of syncopated soul beats, weaving a brilliant dance cloth of iridescent splendour.More>>

Back On The Stairway To Heaven: Led Zeppelin Wins Over Spirit

In March, the 9th US Circuit Court of Appeal upheld an original jury finding that Led Zeppelin’s Stairway to Heaven did not infringe copyright in Spirit’s 1968 song Taurus. Michael Skidmore, who had filed the suit in 2014 as trustee of the ... More>>



  • Wellington
  • Christchurch
  • Auckland